NFKB1 and cancer: The growth inhibitory effect of NO-aspirin, associated with its ability to reduce proliferation and enhance apoptosis of cancer cells, was shown to be significantly correlated to its profound inhibition of the NF-κB signalling pathway, the occurrence of which was suggested to be due to inhibition of NF-κB binding to DNA in the nucleus [55].